SGMT (Sagimet Biosciences Inc) Earnings growth in current year

SGMT (Sagimet Biosciences Inc) - company brandmark

Sagimet Biosciences (SGMT) utilizes a virtual manufacturing model through certified partners, ensuring strict adherence to timelines. The company's high authority in metabolism therapy is evidenced by physician confidence in its unique inhibitors. However, clinical trial uncertainty and intense competition create financial risks. The annual growth of net income per share as a percentage demonstrates volatility, where the 23.20 metric reflects the current trend.

SGMT: Sagimet Biosciences Earnings per share growth in current year 02/21/2024 - 11/18/2026

Financial and market metric breakdowns for Sagimet Biosciences, Inc. (SGMT)

- share price and expert price forecast:
Basic company analysis:SGMT - Sagimet Biosciences Inc
Finished products of Sagimet Biosciences Inc.

The biotech sector's high sensitivity to external shocks necessitates an analysis of profit recovery inertia, measured by the year-over-year percentage change in EPS. Sagimet Biosciences (SGMT) possesses potential in steatohepatitis and oncology therapies that creates a foundation for capitalization; therefore, tracking annual EPS growth allows investors to identify cash flow gaps in a timely manner while assessing the real scaling speed of the company's operational efficiency.

Main competitors

ASND: Net earnings per one share growth for the current year|MDGL (Madrigal Corp) - Earnings growth in current year|Earnings growth in current year Corcept Therapeutics|Earnings growth in current year RYTM|Earnings per share growth in current year AKRO (Akero Therapeutics, Inc.)|Earnings per share growth in current year metsera.com MTSR|MoonLake Corp (MLTX) - Earnings per share growth rate in current year|CRNX - Earnings per share growth in current year|NAMS: Earnings per share growth in current year|SLNO: Earnings growth in current year|FOLD - Expected net earnings per share growth this year|Earnings per share growth in current year 89bio Pharma|Agios Corp (AGIO) - Expected net earnings per share growth this year|Earnings per share growth in current year structuretx.com (GPCR)|Net earnings per share growth this year mimedx.com MDXG|Earnings per share growth in current year Rezolute RZLT|Lexicon Pharmaceuticals, Inc. - Earnings per share growth in current year|MBX: Net earnings per share growth this year|Altimmune Corp - Net earnings per one share growth for the current year|Aardvark Therapeutics Inc (AARD) - Earnings per share growth in current year|Earnings per share growth rate in current year BioAge Labs, Inc. (BIOA)|Earnings per share growth in current year Biomea Fusion Inc|Earnings per share growth this year QNCX (Quince Therapeutics)|Net earnings per share growth this year GUTS (Fractyl Health)|Net earnings per one share growth for the current year VTVT|Agape ATP Corporation - Net earnings per share growth this year|Earnings per share increase in current year PLUR|Synlogic Inc. - Earnings growth in current year|LPCN (Lipocine) - Earnings per share growth this year|MTNB (Matinas BioPharma Holdings Inc.) - Net earnings per share growth this year|SPRB (Spruce Biosciences, Inc.) - Earnings per share growth in current year|GLTO (galecto.com) - Earnings growth in current year|Net earnings per share growth this year carmellrx.com (CTCX)|Earnings per share growth in current year Lumos Pharma (LUMO)|ONVO (Organovo Holdings) - Earnings per share increase in current year|radiuspharm.com - Net earnings per share growth this year